<code id='F94CE1AB41'></code><style id='F94CE1AB41'></style>
    • <acronym id='F94CE1AB41'></acronym>
      <center id='F94CE1AB41'><center id='F94CE1AB41'><tfoot id='F94CE1AB41'></tfoot></center><abbr id='F94CE1AB41'><dir id='F94CE1AB41'><tfoot id='F94CE1AB41'></tfoot><noframes id='F94CE1AB41'>

    • <optgroup id='F94CE1AB41'><strike id='F94CE1AB41'><sup id='F94CE1AB41'></sup></strike><code id='F94CE1AB41'></code></optgroup>
        1. <b id='F94CE1AB41'><label id='F94CE1AB41'><select id='F94CE1AB41'><dt id='F94CE1AB41'><span id='F94CE1AB41'></span></dt></select></label></b><u id='F94CE1AB41'></u>
          <i id='F94CE1AB41'><strike id='F94CE1AB41'><tt id='F94CE1AB41'><pre id='F94CE1AB41'></pre></tt></strike></i>

          Home / comprehensive / hotspot

          hotspot


          hotspot

          author:fashion    Page View:37
          Alexis Borisy
          Venture capitalist Alexis Borisy Vanessa Leroy for STAT

          EQRx is done, sold for its cash.

          The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

          advertisement

          The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In